Skip to main content
User menu
Subscribe
Donate
The HIV Treatment Journal of
Webinars
Current Issue
Drug Guides
Trending
COVID-19 and HIV
HIV Decriminalization
Hepatitis C
U=U
HIV & Aging
HIV Basics
HIV Cure Research
HIV Prevention
HIV Treatment
Stigma & Discrimination
POZ Advocate
Archive
About
Who We Are
Advertise
Contact
Subscribe
Reader/Customer Service
News
Donate
Donate
Bulk Subscriber Donation
Search
HIV Treatment
Back to top
Choice Options
DHHS Guidelines for people starting HIV therapy for the first time
Mar 7, 2020
The Waxing and Waning of HIV Drugs
Medications come and go, but the goal is still the same
By
Mar 7, 2020
Weighty Concerns
What we know for now about weight gain with HIV medications
By
Mar 7, 2020
Contributors
Mar 1, 2020
Briefly
By
Jan 7, 2020
The future is already here
Technological advances in HIV treatment and prevention
By Michelle Simek
Nov 11, 2019
Truvada Safety
Talking about PrEP and HIV treatment in a time of class action lawsuits
By Cori Blum, MD, AAHIVS
Cori Blum, MD, AAHIVS
Nov 7, 2019
Briefly
FDA approves Descovy for PrEP; Delstrigo and Pifeltro approved for switch treatment; Bictegravir, dolutegravir and Tybost for children; and more.
Oct 26, 2019
Exciting news from Mexico City
By
Sep 19, 2019
Dolutegravir during pregnancy
By
Sep 19, 2019
Pagination
Previous page
‹‹
Page 5
Next page
››
Subscribe to HIV Treatment